Advantages, disadvantages of using semaglutide and challenges and future research priorities Semaglutide effectively reduces glycated hemoglobin (HbA1c) levels and body weight across a broad spectrum of patients with type 2 diabetes, while also demonstrating cardiovascular safety [92]
Diarrhea Diarrhea is the second most common gastrointestinal side effect, reported in 10.1% to 29.7% of semaglutide users in clinical trials
It keeps problems away and supports good weight management
Starting July 2026, Wegovy is also one of the three drugs covered under the GLP-1 Bridge program for weight loss at a $50/month copay, manufactured by Novo Nordisk
(Florida), Mochi Medical CA, P.C., Mochi Medical KS, P.A., Mochi Medical NJ, P.C., and similar entities for other states
Contact your healthcare provider promptly if you develop jaundice (yellowing of skin or eyes), dark-colored urine, pale stools, persistent right upper quadrant abdominal pain, or unexplained severe fatigue